DiagnaMed Announces Test Launch of CERVAI™ Brain Health in University Brain Health Center

February 28, 2024

TORONTO, Feb. 28, 2024 (GLOBE NEWSWIRE) — DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB:DGNMF), a digital health artificial intelligence company focused on brain health, today announced a test launch of CERVAI™, a world-first consumer brain health and wellness AI solution, at the University of Miami Comprehensive Center for Brain Health. The initial focus will be evaluating the brain health assessment portion of CERVAI™, which scores brain health by taking a clinically validated assessment for brain resilience, vulnerability and performance functions.

Read more at globenewswire.com

Related news for (DGNMF)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.